353a) FDA Prescription Requirement Under Section 503A (Guidance for Industry) FDA Bulk Drug Substances Used in Compounding Under Section 503A FDA Information for Outsourcing Facilities (503B) FDA FD&C Act Provisions That Apply to Human Drug Compounding FDA Questions and Answers: Outsourcing Facility Registration FDA 503B Bulk Drug Substances List FDA FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List FDA FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize FDA FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients Disclosure: USA MedPremium is a licensed medical supply and pharmaceutical distributor
There are also quality and sourcing concerns, as peptides obtained from unregulated sources may be mislabeled, contaminated, or falsified, which increases risks
Lee S, Lee SM, Lee SH, Choi W-K, Park S-J, Kim DY
This varies depending on your health goals
Depression-related effects appear to be rare based on current clinical trial and post-marketing data